Peloton Wealth Strategists’s Gilead Sciences GILD Stock Holding History

Peloton Wealth Strategists’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-13,460	Closed	-$914K	–	71
2017 Q1	$914K	Sell	13,460 -12,930	-49%	-$909K	0.75%	55
2016 Q4	$1.89M	Sell	26,390 -2,850	-10%	-$212K	1.54%	24
2016 Q3	$2.31M	Buy	+29,240	New	+$2.38M	1.92%	18
2016 Q1	$2.49M	Buy	27,070 +7,770	+40%	+$701K	2.11%	16
2015 Q4	$1.95M	Buy	19,300 +3,200	+20%	+$333K	1.69%	22
2015 Q3	$1.58M	Buy	16,100 +1,400	+10%	+$155K	1.38%	31
2015 Q2	$1.72M	Buy	14,700 +7,700	+110%	+$841K	1.37%	33
2015 Q1	$687K	Buy	+7,000	New	+$711K	0.53%	64
2014 Q3	–	Sell	-29,090	Closed	-$2.43M	–	89
2014 Q2	$2.43M	Buy	+29,090	New	+$2.26M	2.13%	16

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Peloton Wealth Strategists's GILD Position: Q2 2017 in Review

Peloton Wealth Strategists sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 13,460 shares — an estimated $914K sold.

Peloton Wealth Strategists first reported a position in GILD in Q2 2014 and held it in 9 quarters. The position peaked at $2.49M in Q1 2016. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

Peloton Wealth Strategists reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
Peloton Wealth Strategists sold 13,460 Gilead Sciences shares in Q2 2017, an estimated $914K.
Peloton Wealth Strategists first reported a position in Gilead Sciences in Q2 2014 and held it in 9 quarters.
Peloton Wealth Strategists's Gilead Sciences position peaked at $2.49M in Q1 2016.
1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Peloton Wealth Strategists's 13F filing for Q2 2017, filed 10 Aug 2017.